Utility of Esophageal Cooling Therapy for the Prevention of Thermal Injury During Atrial Fibrillation Ablation: an investigator initiated randomized blinded single center pilot study

Recruiting
99 years or below
All
40 participants needed
1 Location

Brief description of study

This is a small scale pilot study to evaluate if esophageal cooling using the Attune Medical Esophageal Heat Transfer Device (EnsoETM) limits the frequency or severity of thermal injury during catheter ablation of atrial fibrillation. This prospective, randomized study will include 40 patients with symptomatic AF undergoing index PVI at the Hospital of the University of Pennsylvania. Patients will be randomized in a 1:1 fashion with 20 patients (Group A) randomized to undergo the ablation procedure with esophageal cooling and the other 20 patients (Group B) will serve as the control group and will not have the EnsoETM device used. Patients randomized to Group A will have the EnsoETM device placed in the electrophysiology laboratory following intubation and prior to the ablation procedure. All patients will undergo oesophagogastroduodenoscopy (EGD) 1-2 days following the ablation procedure.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Atrial Fibrillation
  • Age: 99 years or below
  • Gender: All
Updated on 19 Feb 2024. Study ID: 831401

Find a site

Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Message For Non Enrolling By Invitation Trial

Select a study center that’s convenient for you, and get in touch with the study team.